Impact of oxygen therapy in exertion in physical activity of patients with fibrotic intertitial lung disease with exertional hypoxemia (AFOX study)

Status

Not yet recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-510440-20-00

Acronym

AFOX

Enrollment

Registered

2024-05-24

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibrotic interstitial lung disease

Brief summary

Change in the number of steps per day comparing the control group and the intervention group.

Detailed description

Changes in dyspnea questionnaire (dyspnea-12), quality of life (K-BILD) and anxiety and depression (HADS) between control and intervention group, Evaluate hours per day of oxygen therapy compliance, Analytical changes in oxidative stress between contol and intervention group

Interventions

DRUGOXYGEN

Eligibility

Sex/Gender

All

Age

65 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Change in the number of steps per day comparing the control group and the intervention group.	—

Secondary

Measure	Time frame
Changes in dyspnea questionnaire (dyspnea-12), quality of life (K-BILD) and anxiety and depression (HADS) between control and intervention group, Evaluate hours per day of oxygen therapy compliance, Analytical changes in oxidative stress between contol and intervention group	—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026